MNPR
Price
$33.60
Change
-$1.41 (-4.03%)
Updated
Jun 27 closing price
Capitalization
207.92M
QRON
Price
$0.05
Change
-$0.02 (-28.57%)
Updated
Jun 25 closing price
Capitalization
895.75K
Interact to see
Advertisement

MNPR vs QRON

Header iconMNPR vs QRON Comparison
Open Charts MNPR vs QRONBanner chart's image
Monopar Therapeutics
Price$33.60
Change-$1.41 (-4.03%)
Volume$567.57K
Capitalization207.92M
Qrons
Price$0.05
Change-$0.02 (-28.57%)
Volume$14.58K
Capitalization895.75K
MNPR vs QRON Comparison Chart in %
Loading...
MNPR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
QRON
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
MNPR vs. QRON commentary
Jun 30, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MNPR is a Hold and QRON is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 30, 2025
Stock price -- (MNPR: $33.60 vs. QRON: $0.05)
Brand notoriety: MNPR and QRON are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: MNPR: 1695% vs. QRON: 108%
Market capitalization -- MNPR: $207.92M vs. QRON: $895.75K
MNPR [@Biotechnology] is valued at $207.92M. QRON’s [@Biotechnology] market capitalization is $895.75K. The market cap for tickers in the [@Biotechnology] industry ranges from $299.85B to $0. The average market capitalization across the [@Biotechnology] industry is $2.3B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

MNPR’s FA Score shows that 0 FA rating(s) are green whileQRON’s FA Score has 1 green FA rating(s).

  • MNPR’s FA Score: 0 green, 5 red.
  • QRON’s FA Score: 1 green, 4 red.
According to our system of comparison, MNPR is a better buy in the long-term than QRON.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

MNPR’s TA Score shows that 3 TA indicator(s) are bullish while QRON’s TA Score has 3 bullish TA indicator(s).

  • MNPR’s TA Score: 3 bullish, 4 bearish.
  • QRON’s TA Score: 3 bullish, 3 bearish.
According to our system of comparison, QRON is a better buy in the short-term than MNPR.

Price Growth

MNPR (@Biotechnology) experienced а +2.25% price change this week, while QRON (@Biotechnology) price change was -26.69% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.13%. For the same industry, the average monthly price growth was +31.22%, and the average quarterly price growth was +12.91%.

Industries' Descriptions

@Biotechnology (+4.13% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
MNPR($208M) has a higher market cap than QRON($896K). MNPR YTD gains are higher at: 52.727 vs. QRON (-72.676). QRON has higher annual earnings (EBITDA): -343.38K vs. MNPR (-17.66M). MNPR has more cash in the bank: 54.6M vs. QRON (2.14K). MNPR has less debt than QRON: MNPR (0) vs QRON (382K). MNPR (0) and QRON (0) have equivalent revenues.
MNPRQRONMNPR / QRON
Capitalization208M896K23,214%
EBITDA-17.66M-343.38K5,143%
Gain YTD52.727-72.676-73%
P/E RatioN/AN/A-
Revenue00-
Total Cash54.6M2.14K2,553,789%
Total Debt0382K-
FUNDAMENTALS RATINGS
QRON: Fundamental Ratings
QRON
OUTLOOK RATING
1..100
50
VALUATION
overvalued / fair valued / undervalued
1..100
4
Undervalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
98
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
MNPRQRON
RSI
ODDS (%)
Bullish Trend 3 days ago
84%
Bullish Trend 3 days ago
56%
Stochastic
ODDS (%)
Bullish Trend 3 days ago
75%
Bullish Trend 3 days ago
52%
Momentum
ODDS (%)
Bearish Trend 3 days ago
87%
Bearish Trend 3 days ago
75%
MACD
ODDS (%)
Bullish Trend 3 days ago
73%
Bearish Trend 3 days ago
73%
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
80%
Bearish Trend 3 days ago
76%
TrendMonth
ODDS (%)
Bearish Trend 3 days ago
88%
Bearish Trend 3 days ago
78%
Advances
ODDS (%)
N/A
N/A
Declines
ODDS (%)
Bearish Trend 10 days ago
88%
N/A
BollingerBands
ODDS (%)
N/A
Bullish Trend 3 days ago
53%
Aroon
ODDS (%)
Bearish Trend 3 days ago
88%
Bearish Trend 3 days ago
85%
View a ticker or compare two or three
Interact to see
Advertisement
MNPR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
QRON
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ACLX65.350.58
+0.90%
Arcellx
BOSC4.860.04
+0.83%
B.O.S. Better Online Solutions
FTV71.600.38
+0.53%
Fortive Corp
SPKL10.910.03
+0.27%
Spark I Acquisition Corp
NBR28.17N/A
N/A
Nabors Industries Ltd

MNPR and

Correlation & Price change

A.I.dvisor tells us that MNPR and QNCX have been poorly correlated (+32% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that MNPR and QNCX's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MNPR
1D Price
Change %
MNPR100%
-4.03%
QNCX - MNPR
32%
Poorly correlated
+3.33%
CVKD - MNPR
29%
Poorly correlated
+1.56%
RAPT - MNPR
26%
Poorly correlated
-13.36%
NEUP - MNPR
25%
Poorly correlated
+2.94%
AGIO - MNPR
25%
Poorly correlated
-0.53%
More

QRON and

Correlation & Price change

A.I.dvisor indicates that over the last year, QRON has been loosely correlated with COEP. These tickers have moved in lockstep 36% of the time. This A.I.-generated data suggests there is some statistical probability that if QRON jumps, then COEP could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To QRON
1D Price
Change %
QRON100%
N/A
COEP - QRON
36%
Loosely correlated
-3.11%
SPHDF - QRON
27%
Poorly correlated
N/A
RENB - QRON
25%
Poorly correlated
-16.16%
MNPR - QRON
25%
Poorly correlated
-4.03%
TVGN - QRON
24%
Poorly correlated
+5.08%
More